Zykadia is a medicine containing the active ingredient(s) ceritinib. On this page you will find out more about Zykadia, including side effects, age restrictions, food interactions and whether the medicine is subsidised by the government on the pharmaceutical benefits scheme (PBS)
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional. healthdirect medicines information is not intended for use in an emergency. If you are suffering an acute illness, overdose, or emergency condition, call triple zero (000) and ask for an ambulance.
Reasonable care has been taken to provide accurate information at the time of creation. This information is not intended to substitute medical advice, diagnosis or treatment and should not be exclusively relied on to manage or diagnose a medical condition. Please refer to our terms and conditions.
Active ingredient in this medicine: ceritinib
Information for medicine and pack size:
Zykadia 150 mg hard capsule, 3 x 50
Consumer Medicine Information leaflet:
This leaflet may also be found inside the medicine package. It contains information on side effects, age restrictions and other useful data.
What this medicine is for
Zykadia is indicated as monotherapy for the treatment of adult patients with ALK-positive locally advanced or metastatic non-small cell lung cancer (NSCLC) whose disease has progressed on or who are intolerant of crizotinib. Note to the Indication: This indication is approved based on tumour response rate and duration of response. An improvement in survival or disease-related symptoms has not been established.
Table of characteristics
Capsule Body:opaque white marked with black ink NVR. Cap: opaque blue marked with black ink LDK 150MG. Contents: white to almost white powder.
Images are the copyright of the Pharmacy Guild of Australia
|Dosage Form||Capsule, hard|
|Route of administration||Oral|
150: Not scheduled. Not considered by committee
50: Not scheduled. Not considered by committee
There is one type of pack available.
Pack type 1
|Storage temperature||Store below 30 degrees Celsius|
|Storage conditions||Store in Original Container|
|Life time||24 Months|
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on 1 May 2018
The PBS provides a list of government subsidised medicines available to be dispensed to patients. Further information can be found on the Pharmaceutical Benefits Scheme website.
Is this medication banned in sport?
Check if you can use your medicine whilst playing sport. Search the Australian Sports Anti-Doping Authority (ASADA) database that provides information about the prohibited status of specific medications and/or the active ingredient based on the current World Anti-Doping Agency (WADA) Prohibited List.